Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,082 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of MDR-1 in refractory lymphoma.
Sandor V, Wilson W, Fojo T, Bates SE. Sandor V, et al. Leuk Lymphoma. 1997 Dec;28(1-2):23-31. doi: 10.3109/10428199709058327. Leuk Lymphoma. 1997. PMID: 9498700 Review.
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors.
Wilson WH, Jain V, Bryant G, Cowan KH, Carter C, Cottler-Fox M, Goldspiel B, Steinberg SM, Longo DL, Wittes RE. Wilson WH, et al. J Clin Oncol. 1992 Nov;10(11):1712-22. doi: 10.1200/JCO.1992.10.11.1712. J Clin Oncol. 1992. PMID: 1403054 Clinical Trial.
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas.
Wilson WH, Chabner BA, Bryant G, Bates S, Fojo A, Regis J, Jaffe ES, Steinberg SM, Goldspiel BR, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1995 Feb;13(2):381-6. doi: 10.1200/JCO.1995.13.2.381. J Clin Oncol. 1995. PMID: 7531220 Clinical Trial.
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.
Wilson WH, Jamis-Dow C, Bryant G, Balis FM, Klecker RW, Bates SE, Chabner BA, Steinberg SM, Kohler DR, Wittes RE. Wilson WH, et al. J Clin Oncol. 1995 Aug;13(8):1985-94. doi: 10.1200/JCO.1995.13.8.1985. J Clin Oncol. 1995. PMID: 7636539 Clinical Trial.
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.
Wilson WH, Bates SE, Fojo A, Bryant G, Zhan Z, Regis J, Wittes RE, Jaffe ES, Steinberg SM, Herdt J, et al. Wilson WH, et al. J Clin Oncol. 1995 Aug;13(8):1995-2004. doi: 10.1200/JCO.1995.13.8.1995. J Clin Oncol. 1995. PMID: 7636540 Clinical Trial.
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.
Wilson WH, Bryant G, Bates S, Fojo A, Wittes RE, Steinberg SM, Kohler DR, Jaffe ES, Herdt J, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1993 Aug;11(8):1573-82. doi: 10.1200/JCO.1993.11.8.1573. J Clin Oncol. 1993. PMID: 7687667 Clinical Trial.
Reversal of multidrug resistance.
Bates SE, Zhan Z, Dickstein B, Lee JS, Scala S, Fojo AT, Paull K, Wilson W. Bates SE, et al. Prog Clin Biol Res. 1994;389:33-7. Prog Clin Biol Res. 1994. PMID: 7700913 Review. No abstract available.
Reversal of multidrug resistance.
Bates SE, Zhan Z, Dickstein B, Lee JS, Scala S, Fojo AT, Paull K, Wilson W. Bates SE, et al. J Hematother. 1994 Fall;3(3):219-23. doi: 10.1089/scd.1.1994.3.219. J Hematother. 1994. PMID: 7827870 Review. No abstract available.
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.
Wilson WH, Berg SL, Bryant G, Wittes RE, Bates S, Fojo A, Steinberg SM, Goldspiel BR, Herdt J, O'Shaughnessy J, et al. Wilson WH, et al. J Clin Oncol. 1994 Aug;12(8):1621-9. doi: 10.1200/JCO.1994.12.8.1621. J Clin Oncol. 1994. PMID: 7913721 Clinical Trial.
Drug resistance in adult lymphomas.
Chabner BA, Bates SE, Fojo AT, Spolyar M, Wilson WH. Chabner BA, et al. Semin Hematol. 1994 Jan;31(1):70-87. Semin Hematol. 1994. PMID: 8122136 Review. No abstract available.
4,082 results
Jump to page
Feedback